fropenem has been researched along with Cystitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, S; Hamasuna, R; Hayami, H; Kiyota, H; Kobayashi, K; Matsumoto, T; Takahashi, S; Tanaka, K; Yamamoto, S; Yasuda, M | 1 |
| Fujii, S; Fujino, K; Hashimoto, J; Hiyama, Y; Ichihara, K; Masumori, N; Shinagawa, M; Takahashi, S; Uehara, T | 1 |
| Akatsuka, K; Chimura, T; Funayama, T; Hayashi, Y; Hirayama, T; Kaneko, N; Morisaki, N; Murayama, K; Numazaki, M; Oda, T; Sato, F | 1 |
2 trial(s) available for fropenem and Cystitis
| Article | Year |
|---|---|
Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cystitis; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2014 |
[Clinical studies of faropenem in the field of obstetrics and gynecology].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cystitis; Female; Genital Diseases, Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lactams; Mastitis; Middle Aged; Pelvic Inflammatory Disease; Uterine Cervicitis; Uterine Diseases | 1999 |
1 other study(ies) available for fropenem and Cystitis
| Article | Year |
|---|---|
The efficacy of faropenem for patients with acute cystitis caused by extended spectrum β-lactamase producing Escherichia coli.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cystitis; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult | 2017 |